BRIEF

on VALBIOTIS (EPA:ALVAL)

VALBIOTIS SA: Monthly update on voting rights and share capital

Stock price chart of VALBIOTIS (EPA:ALVAL) showing fluctuations.

VALBIOTIS SA, based in Périgny, has published its monthly update in accordance with Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. As of March 31, 2025, the total number of shares comprising the share capital amounts to 15,794,596. The total number of theoretical voting rights is 16,486,754, while the number of exercisable voting rights reaches 16,450,649, after deduction of treasury shares.

The company reiterates Article 10.5 of its articles of association regarding threshold crossings. Any holder of 5% or more of the capital must notify the company, failing which they will lose their voting rights for these shares if they fail to comply.

VALBIOTIS, listed on Euronext Growth Paris, specializes in the design of innovative dietary supplements for cardiometabolic well-being. The company is a member of the BPI Excellence network and receives financial support from the European Union.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all VALBIOTIS news